BASTA STEVEN L (President and CEO) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/19/2025ACC: 0001193125-25-327126
DirectorOfficer· President and CEO
Since Feb 2026
+30.54K
Net shares
Net buyer
$483.9K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
62.04K acquired · 31.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+62.04K
Price / share
—
Trade value
—
% of position
74.5%
12/17/2025
83.25K→145.29K
Common Stock
Direct
Shares
−31.50K
Price / share
$15.36
Trade value
$483.87K
% of position
21.7%
12/17/2025
145.29K→113.79K
Total
Net shares
+30.54K
Net value
-$483.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2025 | A · Award | +62.04K | — | — | 74.5% | 83.25K | 145.29K |
| Common Stock Direct | 12/17/2025 | F · Tax Withholding | −31.50K | $15.36 | $483.87K | 21.7% | 145.29K | 113.79K |
| Total | +30.54K | -$483.87K | ||||||
Derivative Transactions0
No derivative transactions reported